Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 2
1(50.0%)
2Total
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06028672Not ApplicableRecruiting

Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6

Role: collaborator

NCT06020755Phase 2Recruiting

Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7

Role: collaborator

NCT04025047Recruiting

A Multi-center Registry Study: The Follow-up the Complications for Trans-vaginal Mesh Surgery

Role: collaborator

NCT02887963Completed

Epidemiological Study of Iron Deficiency and Iron Deficiency Anemia in Chinese Pregnant Women

Role: collaborator

All 4 trials loaded